Hypercalcemia and acute pancreatitis in a male patient with acute promyelocytic leukemia and pulmonary tuberculosis.

Autor: Abdullah AS; Resident, Internal Medicine, Hamad Medical Corporation (HMC), Doha, Qatar. yassinmoha@gmail.com., Adel AM; Pharmacists, Department of Pharmacy, NCCCR, Hamad Medical Corporation (HMC), Doha, Qatar. yassinmoha@gmail.com., Hussein RM; Pharmacists, Department of Pharmacy, NCCCR, Hamad Medical Corporation (HMC), Doha, Qatar. yassinmoha@gmail.com., Abdullah MA; Hematologists, Department of Hematology, NCCCR, Hamad Medical Corporation (HMC), Doha, Qatar. yassinmoha@gmail.com., Yousaf A; Hematologists, Department of Hematology, NCCCR, Hamad Medical Corporation (HMC), Doha, Qatar. yassinmoha@gmail.com., Mudawi D; Hematologists, Department of Hematology, NCCCR, Hamad Medical Corporation (HMC), Doha, Qatar. yassinmoha@gmail.com., Mohamed SF; Hematologists, Department of Hematology, NCCCR, Hamad Medical Corporation (HMC), Doha, Qatar. yassinmoha@gmail.com., Nashwan AJ; Nurse Research Scientist, Cancer Clinical Trials Unit, NCCCR, Hamad Medical Corporation (HMC), Doha, qatar. yassinmoha@gmail.com., Soliman D; Department of Laboratory Medicine and Pathology, National Center for Cancer Care and Research, Hamad Medical Corporation (HMC), Doha, Qatar and Department of Clinical Pathology, National Cancer Institute, Cairo University,Cairo, Egypt. yassinmoha@gmail.com., Ibrahim F; Consultant Hematopathologist Department of Laboratory Medicine and Pathology, National Center for Cancer Care and Research, Hamad Medical Corporation (HMC), Doha, Qatar. yassinmoha@gmail.com., Yassin MA; Hematologists, Department of Hematology, NCCCR, Hamad Medical Corporation (HMC), Doha, Qatar. yassinmoha@gmail.com.
Jazyk: angličtina
Zdroj: Acta bio-medica : Atenei Parmensis [Acta Biomed] 2018 Apr 03; Vol. 89 (3-S), pp. 23-27. Date of Electronic Publication: 2018 Apr 03.
DOI: 10.23750/abm.v89i3-S.7216
Abstrakt: We report a rare case of hypercalcemia and acute pancreatitis in a subject with acute promyelocytic leukemia (APL) and pulmonary tuberculosis, during all-trans-retinoic acid (ATRA) treatment. Both associated complications were potentially due to several causes. A careful monitoring and exclusion of all causative factors must be addressed. Further research is necessary to improve our understanding of risk factors for these complications in patients with (APL). Studying these patterns may help us to improve outcomes for all children and young adults with hematologic malignancies.
Databáze: MEDLINE
Externí odkaz: